Royalty Pharma ( NASDAQ:RPRX ) Full Year 2023 Results Key Financial Results Revenue: US$2.35b (up 5.2% from FY 2022…
Read full NASCAR article on Yahoo Sports
Read all NASCAR articles
Home » Royalty Pharma Full Year 2023 Earnings: EPS: US$2.54 (vs US$0.098 in FY 2022)